This feature article discusses the top FDA-related issues that the medical device industry is keeping an eye on for the 2019 year. Among those top concerns are new regulations involving laboratory developed tests (LDTs), digital health apps and medical device cybersecurity, among others. Aaron Josephson, senior director at ML Strategies and a former senior policy advisor at FDA’s device center, is among the industry sources quoted.

Source

InsideHealthPolicy